Scott Kowalski
Pain Medicine · Orange Park, FLNPI 1891729166
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,165 of the $6,887 with a category attached, or 89.5%. It is spread thinly across 33 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,055 and has fallen 90.2% since, to $201 in 2025.
Across 252 payments — averaging $27.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Vertos Medical, Inc.$1K
- Nevro Corp.$903
- Medtronic$452
- Abbott$404
- Collegium Pharmaceutical, Inc.$341
- plus $2K from 27 others
What the payments were for
- Travel & lodging$72210%
- Food & beverage$6,16590%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 76 | $1,245 |
| Vertos Medical, Inc. | 10 | $1,132 |
| Nevro Corp. | 16 | $903 |
| Medtronic | 10 | $452 |
| Abbott | 14 | $404 |
| Collegium Pharmaceutical, Inc. | 20 | $341 |
| Amgen | 15 | $320 |
| Idorsia Pharmaceuticals US Inc | 18 | $258 |
| Ferring Pharmaceuticals Inc. | 10 | $201 |
| Boston Scientific | 6 | $192 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $187 |
| Biohaven Pharmaceuticals, Inc. | 6 | $149 |
| Relievant Medsystems, Inc. | 1 | $129 |
| Tersera Therapeutics LLC | 6 | $122 |
| Biodelivery Sciences International, Inc. | 2 | $117 |
| Pear Therapeutics (US), Inc. | 1 | $112 |
| Globus Medical | 1 | $107 |
| Redhill Biopharma Inc. | 4 | $70 |
| Novartis | 3 | $48 |
| Stimwave Technologies Incorporated | 3 | $47 |
| Arbor Pharmaceuticals, Inc. | 3 | $41 |
| Amneal Pharmaceuticals LLC | 2 | $39 |
| Lundbeck LLC | 2 | $38 |
| Eisai Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Sanofi | 1 | $28 |
| Curonix LLC | 1 | $24 |
| Protega Pharmaceutials Inc | 1 | $22 |
| Bioventus LLC | 1 | $20 |
| Biogen | 1 | $17 |
| Pfizer | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$767
- Senza Spinal Cord Stimulation System$445
- Intracept$258
- INTELLIS ADAPTIVESTIM$238
- Senza$238
- RESET-O$112
- BELBUCA$111
- Symproic$111
How this compares
$6,887 in reported general payments places this provider in the 70th percentile of 596 pain medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 16 | $296 |
| Tizanidine Hcl | 15 | $272 |
| Alprazolam | 19 | $10 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Orange Park
- Jeffrey GudinMiami$356K
- Joseph PergolizziNaples$333K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
- Mark-Friedrich HurdleJacksonville$140K
- Rodolfo GariTampa$120K
- Stephen PylesOcala$115K
- Orlando FloreteJacksonville$86K
- Michael GreeneMiddleburg$73K
- Nicholas BremerFernandina Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.